Five Ways Our Scientists Are Working Toward a World Without Alzheimer’s

Walkers carry flower spinners to remember the people they walk for during the Alzheimer Association's 2026 Walk to End Alzheimer's on October 31. They pass a table of waving Wertheim UF Scripps staff.
A parade of people carry flower spinners as they walk through the Wertheim UF Scripps courtyard, remembering the people they walk for during the Alzheimer Association’s 2026 Walk to End Alzheimer’s on October 31. They pass a table of waving Wertheim UF Scripps staff.

Everyone knows a family affected by Alzheimer’s disease. It’s a leading cause of death in the United States, ranking 7th among all causes. About 1 in 9 people age 65 and older have Alzheimer’s. Nationwide, 13 million people in the U.S. provide care for a loved one with the illness or a related dementia.

Scientists at The Wertheim UF Scripps Institute are working to understand the causes of brain degenerative diseases, and designing potential new treatments, in collaboration with our specialists in structural biology, medicinal chemistry and drug metabolism.

Here are five ways they’re making real progress:

  • Developing therapeutics that protect the cell’s energy supply: Neuroscientist Ronald Davis, Ph.D., designs treatments to protect mitochondria, the organells that provide cells with their energy. Brain cells are the most energy-hungry cells in the body, and if they lack energy, they can die. Davis has identified compounds that protect mitochondria and extend the lives of neurons, in lab studies.
  • Targeting RNA molecules: Chemist Matthew D. Disney, Ph.D., engineers medications that act on RNA, the cellular workers that read genes and build proteins. His Alzheimer’s targets include RNA that build a toxic form of a protein called tau. In a healthy neuron, tau helps provide the structural support that gives a neuron its shape. But damaged or diseased tau can form tangles and lead a neuron to fall apart and die.
  • Evaluating how genes control the density of synapses: Sathya Puthanveettil, Ph.D., is studying how a gene called SLAMR affects connections among brain cells in Alzheimer’s models, with a goal of creating targeted RNA therapeutics. His team studies cellular “motor” proteins to find new ways to halt brain cell death and memory loss.
  • Correcting brain cell connections: Jinyoung Kang, Ph.D., blends engineering and chemistry, inventing new microscopy techniques to see synapses in new ways. She is uncovering the mechanisms that drive synapse loss in Alzheimer’s and lead to progressive cognitive decline.
  • Exploring how toxic protein clumps damage the connection points between brain cells: Gavin Rumbaugh, Ph.D., researches a gene called SynGAP that affects brain cell connections. He is testing targeted compounds to repair communication networks.

Thank you for supporting Alzheimer’s research! If you would like to directly support Alzheimer’s research at The Wertheim UF Scripps Institute, please visit our giving page or contact us at 561-228-2033.


Working to End Alzheimer’s

Click through the photos to see how scientists at the institute are working toward a healthier future.